James V. Cassella's Insider Trades & SAST Disclosures
James V. Cassella's most recent trade in Trevi Therapeutics Inc was a trade of 257,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James V. Cassella.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Trevi Therapeutics Inc | James V. Cassella | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 257,500 | 257,500 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | James V. Cassella | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | James V. Cassella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | James V. Cassella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | James V. Cassella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | James V. Cassella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges